SCHEMBL1616741

SCHEMBL1616741

c1ccc2c(c1)CC[C@H]2Nc1ccc2c(Nc3ccc4[nH]ccc4c3)cccc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 2/20 0.42
TGFBR1 P36897 1/20 0.40
FADS1 O60427 1/20 0.38
PRKD1 Q15139 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KCNN3 Q9UGI6 1/20 0.37
EGFR P00533 2/20 0.36
FLT1 P17948 2/20 0.36
KDR P35968 1/20 0.36
GBA1 P04062 1/20 0.36
PFKFB3 Q16875 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
HSD11B1 P28845 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35
ULK1 O75385 1/20 0.34
LYN P07948 1/20 0.34
PRKCQ Q04759 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616700 0.94 CDK1 (0.44) CDK1FADS1HDAC6KCNN3EGFR
SCHEMBL1616399 0.87 HDAC6 (0.43) CDK1FADS1HDAC6KCNN3GBA1
SCHEMBL1615740 0.83 SYK (0.39) CDK1FADS1HDAC6KCNN3EGFR
SCHEMBL1615579 0.82 PFKFB3 (0.42) FADS1HDAC6KCNN3GBA1PFKFB3
SCHEMBL1616678 0.82 FADS1 (0.47) CDK1FADS1HDAC6KCNN3GBA1
SCHEMBL1616631 0.78 HDAC6 (0.43) CDK1FADS1HDAC6KCNN3GBA1
SCHEMBL1616633 0.78 HDAC6 (0.43) CDK1FADS1HDAC6KCNN3GBA1
SCHEMBL1616386 0.78 GBA1 (0.41) CDK1FADS1HDAC6KCNN3EGFR
SCHEMBL1616104 0.78 HDAC6 (0.38) FADS1HDAC6KCNN3GBA1TRPV1
SCHEMBL3844986 0.77 PDPK1 (0.47) FADS1HDAC6KCNN3EGFRGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US claimed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP claimed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP claimed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US claimed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO claimed
US-7923561-B2 Quinolines HOFFMANN-LA ROCHE INC. (US) 2011-04-12 US disclosed
EP-2099763-B1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-08-11 EP disclosed
EP-2099763-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2009-09-16 EP disclosed
US-20080146567-A1 QUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2008-06-19 US disclosed
WO-2008068157-A1 2-AMINOQUINOLINES AS 5-HT(5A) RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146567-A1 QUINOLINES HTR5A, HTR2B, HTR2C CDK1 1932/4885TGFBR1 1476/4885FADS1 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.